Advertisement

Antibiotic Therapy

  • Wesley Leung
  • Andres GelrudEmail author
Chapter
  • 1.7k Downloads

Abstract

Despite advances in supportive care for patients with acute necrotizing pancreatitis, the majority of patients who die succumb to infectious complications often late (2–4 weeks) in the disease process. Research completed over the past two decades has improved our understanding of infectious complications in patients with acute pancreatitis. Patients with acute necrotizing pancreatitis are at the greatest risk of developing an infection with bacteria translocated from the bowel lumen into the necrotic pancreatic tissue. The most effective antimicrobial agents are the fluoroquinolones and carbapenems, which achieve optimal pancreatic tissue penetration and inhibit the growth of enteric bacteria present in pancreatic infection juice and necrotic tissue. The role of antibiotics in reducing infectious morbidity and mortality has been debated for decades, but current evidence does not support the use of prophylactic antibiotics for the prevention of infection of sterile necrosis. In cases of suspected infected pancreatic necrosis (IPN), antibiotic therapy should be initiated while the source of the infection is being investigated. If no source of infection is identified, antibiotics should be discontinued. Recent evidence suggests a select group of patients with IPN can be managed by antibiotics alone without requiring percutaneous drainage or necrosectomy. However, if these patients deteriorate clinically, more aggressive therapy is warranted.

Keywords

Acute Pancreatitis Clostridium Difficile Infection Pancreatic Tissue Severe Acute Pancreatitis Bacterial Translocation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med. 2006;354:2142–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Garg PK, Madan K, Pande GK, Khanna S, Sathyanarayan G, Bohidar NP, et al. Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis. Clin Gastroenterol Hepatol. 2005;3:159–66.PubMedCrossRefGoogle Scholar
  3. 3.
    Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg. 1999;86:1020–4.PubMedCrossRefGoogle Scholar
  4. 4.
    van Santvoort HC, Bakker OJ, Bollen TL, Besselink MG, Ahmed Ali U, Schrijver AM, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology. 2011;141:1254–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Beger HG, Büchler M, Bittner R, Oettinger W, Block S, Nevalainen T. Necrosectomy and postoperative local lavage in patients with necrotizing pancreatitis: results of a prospective clinical trial. World J Surg. 1988;12:255–62.PubMedCrossRefGoogle Scholar
  6. 6.
    Besselink MG, van Santvoort HC, Boermeester MA, Nieuwenhuijs VB, van Goor H, Dejong CH, et al. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009;96:267–73.PubMedCrossRefGoogle Scholar
  7. 7.
    Baril NB, Ralls PW, Wren SM, Selby RR, Radin R, Parekh D, et al. Does an infected peripancreatic fluid collection or abscess mandate operation? Ann Surg. 2000;231:361–7.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379.PubMedCrossRefGoogle Scholar
  9. 9.
    Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, McMahon MJ. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999;3(3):252–62.PubMedCrossRefGoogle Scholar
  10. 10.
    Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg. 2003;7(1):26–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Dervenis C, Smailis D, Hatzitheoklitos E. Bacterial translocation and its prevention in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2003;10:415–8.PubMedCrossRefGoogle Scholar
  12. 12.
    van Santvoort HC, Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG. Probiotics in surgery. Surgery. 2008;143:1–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Burns GP, Stein TA, Kabnick LS. Blood-pancreatic juice barrier to antibiotic excretion. Am J Surg. 1986;151:205–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Büchler M, Malfertheiner P, Friess H, Isenmann R, Vanek E, Grimm H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103(6):1902–8.PubMedGoogle Scholar
  15. 15.
    Kramer KM, Levy H. Prophylactic antibiotics for severe acute pancreatitis: the beginning of an era. Pharmacotherapy. 1999;19(5):592–602.PubMedCrossRefGoogle Scholar
  16. 16.
    Barie PS. A critical review of antibiotic prophylaxis in severe acute pancreatitis. Am J Surg. 1996;172(6A):38S–43S.PubMedCrossRefGoogle Scholar
  17. 17.
    Pederzoli P, Orcalli F, Falconi M, Bozzini L, Martini N. Penetration of mezlocillin into pancreatic juice. J Antimicrob Chemother. 1986;17:397.PubMedCrossRefGoogle Scholar
  18. 18.
    Roberts EA, Williams RJ. Ampicillin concentrations in pancreatic fluid bile obtained at endoscopic retrograde cholangiopancreatography (ERCP). Scand J Gastroenterol. 1979;14:669–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Koch K, Drewelow B, Liebe S, Reding R, Riethling AK. Die Pankreasgängigkeit von Antibiotica. Chirurg. 1991;62:317–22.PubMedGoogle Scholar
  20. 20.
    Brattstrom C, Malmborg A-S, Tyden G. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man. Surgery. 1988;103:563–7.PubMedGoogle Scholar
  21. 21.
    Gregg JA, Maher L, DeGirolami PC, Gregg Jr JA. Secretion of b-lactam antibiotics in pure human pancreatic juice. Am J Surg. 1985;150:333–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Pederzoli P, Falconi M, Bassi C, Girelli R, Vesentini S, Martini N, et al. Ofloxacin penetration into bile and pancreatic juice. J Antimicrob Chemother. 1989;23:805–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Pederzoli P, Falconi M, Bassi C, Vesentini S, Orcalli F, Scaglione F, et al. Ciprofloxacin penetration in pancreatic juice. Chemotherapy. 1987;33:397–401.PubMedCrossRefGoogle Scholar
  24. 24.
    Bassi C, Pederzoli P, Vesentini S, Falconi M, Bonora A, Abbas H, et al. Behavior of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother. 1994;38:830–6.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Drewelow B, Koch K, Otto C, Franke A, Riethling AK. Penetration of ceftazidime into human pancreas. Infection. 1993;21:229–34.PubMedCrossRefGoogle Scholar
  26. 26.
    Buchler M, Malfertheiner P, Frieß H, Isenmann R, Vanek E, Grimm H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103:1902–8.PubMedGoogle Scholar
  27. 27.
    Koch K, Drewelow B, Brinckmann W. Die Pankreaspenetration von Ofloxacin: Eine Pilotstudie. Z Gastroenterol. 1993;31:587–91.PubMedGoogle Scholar
  28. 28.
    Lankisch PG, Klesel N, Seeger K, Seidel G, Winckler K. Penetration of cefotaxime into the pancreas. Z Gastroenterol. 1983;21:601–3.PubMedGoogle Scholar
  29. 29.
    Benveniste GL, Morris RG. Penetration of cefotaxime into pancreatic juice. Lancet. 1985;1:588–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Widdison AL, Karanjia ND, Reber HA. Antimicrobial treatment of pancreatic infection in cats. Br J Surg. 1994;81:886–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Araida T, Frey CF, Ruebner B, Carlson J, King J. Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a b-agonist, and antibiotics. Pancreas. 1995;11:132–40.PubMedCrossRefGoogle Scholar
  32. 32.
    Foitzik T, Fernández-del Castillo C, Ferraro MJ, Mithöfer K, Rattner DW, Warshaw AL. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg. 1995;222:179–85.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Intern Med. 1975;83:831–2.PubMedCrossRefGoogle Scholar
  34. 34.
    Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg. 1976;183:667–71.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Howes R, Zuidema GD, Cameron JL. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res. 1975;18:197–200.PubMedCrossRefGoogle Scholar
  36. 36.
    Trudel JL, Wittnich C, Brown RA. Antibiotics bioavailability in acute experimental pancreatitis. J Am Coll Surg. 1994;178:475–9.PubMedGoogle Scholar
  37. 37.
    de Vries AC, Besselink MG, Buskens E, Ridwan BU, Schipper M, van Erpecum KJ, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7:531–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Villatoro E, Bassi C, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2006; CD002941.Google Scholar
  39. 39.
    Wittau M, Mayer B, Scheele J, Henne-Bruns D, Dellinger EP, Isenmann R. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol. 2011;46:261–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2010:CD002941.Google Scholar
  41. 41.
    Jiang K, Huang W, Yang XN, Xia Q. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol. 2012;18:279–84.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–244.PubMedCrossRefGoogle Scholar
  43. 43.
    Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15; 1416.Google Scholar
  44. 44.
    Bakker OJ, van Santvoort HC, Besselink MG, van der Harst E, Hofker HS, Gooszen HG, Dutch Pancreatitis Study Group. Prevention, detection, and management of infected necrosis in severe acute pancreatitis. Curr Gastroenterol Rep. 2009;11:104–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Grewe M, Tsiotos GG, Luque de-Leon E, Sarr MG. Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg. 1999;188:408.PubMedCrossRefGoogle Scholar
  46. 46.
    Isenmann R, Schwarz M, Rau B, Trautmann M, Schober W, Beger HG. Characteristics of infection with Candida species in patients with necrotizing pancreatitis. World J Surg. 2002;26:372.PubMedCrossRefGoogle Scholar
  47. 47.
    Gloor B, Müller CA, Worni M, Stahel PF, Redaelli C, Uhl W, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg. 2001;136:592.PubMedCrossRefGoogle Scholar
  48. 48.
    Trikudanathan G, Navaneethan U, Vege SS. Intra-abdominal fungal infections complicating acute pancreatitis: a review. Am J Gastroenterol. 2011;106:1188–92.PubMedCrossRefGoogle Scholar
  49. 49.
    Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57–65.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Sun S, Yang K, He X, Tian J, Ma B, Jiang L. Langenbecks probiotics in patients with severe acute pancreatitis: a meta-analysis. Arch Surg. 2009;394:171–7.CrossRefGoogle Scholar
  52. 52.
    Hartwig W, Maksan SM, Foitzik T, Schmidt J, Herfarth C, Klar E. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg. 2002;6:481–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Dubner H, Steinberg W, Hill M, Bassi C, Chardavoyne R, Bank S. Infected pancreatic necrosis and peripancreatic fluid collections: serendipitous response to antibiotics and medical therapy in three patients. Pancreas. 1996;12:298.PubMedCrossRefGoogle Scholar
  54. 54.
    Runzi M, Niebel W, Goebell H, Gerken G, Layer P. Severe acute pancreatitis: non surgical treatment of infected necrosis. Pancreas. 2005;30:195–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Garg PK, Sharma M, Madan K, Sahni P, Banerjee D, Goyal R. Primary conservative treatment results in mortality comparable to surgery in patients with infected pancreatic necrosis. Clin Gastroenterol Hepatol. 2010;8:1089–94.PubMedCrossRefGoogle Scholar
  56. 56.
    Mouli VP, Vishnubhatla S, Garg PK. Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis. Gastroenterology. 2013;144:333–40.PubMedCrossRefGoogle Scholar
  57. 57.
    van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester MA, Dejong CH, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362:1491–502.PubMedCrossRefGoogle Scholar
  58. 58.
    Buchler MW, Gloor B, Musller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg. 2000;232:619–26.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Tenner SM, Feng S, Noerdook S, Noordhoek E, Feng S, Zinner M, et al. The relationship of organ failure to pancreatic necrosis. Gastroenterology. 1997;113:899–903.PubMedCrossRefGoogle Scholar
  60. 60.
    Evans WK, Ho C-S, McLoughlin MJ, Tao LC. Fatal necrotizing pancreatitis following fine-needle aspiration biopsy of the pancreas. Radiology. 1981;141(1):61–2.PubMedCrossRefGoogle Scholar
  61. 61.
    Levin DP, Bret PM. Percutaneous fine-needle aspiration biopsy of the pancreas resulting in death. Gastrointest Radiol. 1991;16:67–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Lankisch PG, Weber-Dany B, Lerch MM. Clinical perspectives in pancreatology: compliance with acute pancreatitis guidelines in Germany. Pancreatology. 2005;5:591–3.PubMedCrossRefGoogle Scholar
  63. 63.
    Morimoto A, Imamura T, Ishii R, Nakabayashi Y, Nakatani T, Sakagami J, et al. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic. Cancer. 2008;113:1362.PubMedCrossRefGoogle Scholar
  64. 64.
    Pappas T. Is CT, guided fine needle aspiration helpful in patients with infected necrosis. Am J Gastroenterol. 2005;100:2371–4.CrossRefGoogle Scholar
  65. 65.
    Freeman MF, Werner J, van Santvoort HC, Baron TH, Besselink MG, Windsor JA, et al. Interventions for necrotizing pancreatitis. Summary of a multi-disciplinary consensus conference. Pancreas. 2012;8:1176–94.CrossRefGoogle Scholar
  66. 66.
    Seifert H, Biermer M, Schmitt W, Jürgensen C, Will U, Gerlach R, et al. Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study). Gut. 2009;58:1260–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Medicine, Section of GastroenterologyCenter for Endoscopic Research and Therapeutics, University of ChicagoChicagoUSA

Personalised recommendations